Skip to main content
logo
Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.270
-0.070 (-5.22%)
Jul 30, 2026, 9:30 AM EDT - Market open

Alzamend Neuro Cash Flow Statement

Millions USD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Income
-8.77-4.51-9.95-14.88-12.36
Depreciation & Amortization
0.110.050.050.020
Stock-Based Compensation
0.710.330.963.584.41
Other Adjustments
-0.010-0.01
Changes in Accounts Payable
0.71-2.290.051.710.69
Changes in Other Operating Activities
-0.83-0.150.620.640.63
Operating Cash Flow
-8.07-6.57-8.27-8.92-6.61
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Capital Expenditures
--0.3-0.15--0.11
Investing Cash Flow
--0.3-0.15--0.11

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Long-Term Debt Issued
--0.3--
Net Long-Term Debt Issued (Repaid)
--0.3--
Issuance of Common Stock
0.792.71.25018.91
Net Common Stock Issued (Repurchased)
0.792.71.25018.91
Issuance of Preferred Stock
4.047.742.1--
Net Preferred Stock Issued (Repurchased)
4.047.742.1--
Other Financing Activities
-----0.06
Financing Cash Flow
4.8310.443.65018.85

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Cash Flow
-3.243.57-4.76-8.9212.13

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
-8.07-6.87-8.42-8.92-6.72
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.42-15.24-113.48-123.53-101.83
Levered Free Cash Flow
-8.78-7.79-9.07-12.51-11.14
Unlevered Free Cash Flow
-8.77-7.18-9.36-12.5-11.1
SEC Filings: 10-K · 10-Q